TEFÉ-SILVA, C.; RODRIGUES, B. G.; PASCOAL, B. B.; MINANTE, B. I.; VITORELI, B. C.; DE SOUSA, B.; ARROS, I. S. B.; FORTUNATO, I. M.; DE CASTRO, S. C. TRASTUZUMAB DERUXTECAN: NOVEL ANTIBODY-DRUG CONJUGATE TARGETING HER2 IN PATIENTS WITH GASTRIC ADENOCARCINOMA. Journal of Applied Pharmaceutical Sciences and Research, v. 5, n. 4, p. 1-6, 5 abr. 2023.